Log in
Enquire now
Exavir Therapeutics

Exavir Therapeutics

Exavir Therapeutics is a New York City-based company founded by Alborz Yazdi, Howard Gendelman and Benson Edagwa.

OverviewStructured DataIssuesContributors

Contents

exavirtherapeutics.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Healthcare
Healthcare
Therapeutics
Therapeutics
Location
New York City
New York City
B2X
B2B
B2B
0
Founder
‌
Benson Edagwa
0
Howard Gendelman
Howard Gendelman
0
Alborz Yazdi
Alborz Yazdi
0
Pitchbook URL
pitchbook.com/profiles...497234-98
Number of Employees (Ranges)
1 – 10
Email Address
media@exavirtx.com0
Investors
AlleyCorp
AlleyCorp
Gilead Sciences
Gilead Sciences
Total Funding Amount (USD)
4,000,000
Latest Funding Type
Seed
Seed

Other attributes

Company Operating Status
Active

Exavir Therapeutics is a preclinical stage biotechnology company dedicated to eliminating HIV and other viral infections with a broad modality-agnostic approach, beginning with long-acting antiviral therapeutics.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Exavir Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.